Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
The latest announcement is out from Totally ( (GB:TLY) ).
Totally announced that its NHS 111 National Resilience support contract with NHS England will not be renewed, concluding on 15 February 2025, as part of NHS England’s strategic shift away from national-level resilience services. Despite the contract’s conclusion, Totally remains confident in meeting its FY25 performance targets, with expected revenues of £85 million and £3.5 million in EBITDA. The company aims to redeploy its workforce and secure new contracts, expecting its FY26 financial performance to align with FY25 levels. Totally continues to engage with NHS commissioners to mitigate high demand impacts and remains committed to delivering efficient telephony and clinical assessment services.
More about Totally
Totally is a prominent provider of healthcare and wellbeing services across the UK and Ireland, collaborating with the NHS, other healthcare providers, and corporate clients to address the growing demand for healthcare services. The company offers a range of services, including urgent care, elective care, and community health services, with a focus on efficient patient access to appropriate care.
YTD Price Performance: -6.90%
Average Trading Volume: 423,373
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: £13.27M
See more data about TLY stock on TipRanks’ Stock Analysis page.
